BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27537539)

  • 1. Pasireotide for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy: A Cost-effectiveness Analysis.
    Goyert N; Eeson G; Kagedan DJ; Behman R; Lemke M; Hallet J; Mittmann N; Law C; Karanicolas PJ; Coburn NG
    Ann Surg; 2017 Jan; 265(1):2-10. PubMed ID: 27537539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes.
    Abbott DE; Sutton JM; Jernigan PL; Chang A; Frye P; Shah SA; Schauer DP; Eckman MH; Ahmad SA; Sussman JJ
    J Surg Oncol; 2016 Jun; 113(7):784-8. PubMed ID: 27041733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial.
    Ma LW; Dominguez-Rosado I; Gennarelli RL; Bach PB; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Brennan MF; Jarnagin WR; Allen PJ
    Ann Surg; 2017 Jan; 265(1):11-16. PubMed ID: 27429029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis.
    Denbo JW; Slack RS; Bruno M; Cloyd JM; Prakash L; Fleming JB; Kim MP; Aloia TA; Vauthey JN; Lee JE; Katz MH
    J Gastrointest Surg; 2017 Apr; 21(4):636-646. PubMed ID: 28050766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after Pancreatectomy with Routine Pasireotide Use.
    Kunstman JW; Goldman DA; Gönen M; Balachandran VP; D'Angelica MI; Kingham TP; Jarnagin WR; Allen PJ
    J Am Coll Surg; 2019 Feb; 228(2):161-170.e2. PubMed ID: 30414453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
    Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
    Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
    Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppänen H
    Pancreatology; 2020 Jun; 20(4):757-761. PubMed ID: 32307251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.
    Young S; Sung ML; Lee JA; DiFronzo LA; O'Connor VV
    HPB (Oxford); 2018 Sep; 20(9):834-840. PubMed ID: 30060910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy.
    Anderson R; Dunki-Jacobs E; Burnett N; Scoggins C; McMasters K; Martin RC
    World J Surg; 2014 Aug; 38(8):2138-44. PubMed ID: 24663483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula.
    Dalton EC; Johns MS; Rhodes L; Merritt WT; Petrelli NJ; Tiesi GJ
    Am Surg; 2020 Dec; 86(12):1728-1735. PubMed ID: 32870029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pasireotide for postoperative pancreatic fistula.
    Allen PJ; Gönen M; Brennan MF; Bucknor AA; Robinson LM; Pappas MM; Carlucci KE; D'Angelica MI; DeMatteo RP; Kingham TP; Fong Y; Jarnagin WR
    N Engl J Med; 2014 May; 370(21):2014-22. PubMed ID: 24849084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience.
    Dominguez-Rosado I; Fields RC; Woolsey CA; Williams G; Horwedel TA; Rose JB; Hammill CW; Doyle MB; Chapman WC; Strasberg SM; Hawkins WG; Sanford DE
    J Am Coll Surg; 2018 Feb; 226(2):147-154.e1. PubMed ID: 29133263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Hydrocortisone vs Pasireotide on Pancreatic Surgery Complications in Patients With High Risk of Pancreatic Fistula: A Randomized Clinical Trial.
    Tarvainen T; Sirén J; Kokkola A; Sallinen V
    JAMA Surg; 2020 Apr; 155(4):291-298. PubMed ID: 32022887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pasireotide does not prevent postoperative pancreatic fistula: a prospective study.
    Elliott IA; Dann AM; Ghukasyan R; Damato L; Girgis MD; King JC; Hines OJ; Reber HA; Donahue TR
    HPB (Oxford); 2018 May; 20(5):418-422. PubMed ID: 29398424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection.
    Rosenberg L; MacNeil P; Turcotte L
    J Gastrointest Surg; 1999; 3(3):225-32. PubMed ID: 10481115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula.
    Dalton EC; Johns MS; Rhodes L; Merritt WT; Petrelli NJ; Tiesi GG
    Am Surg; 2020 May; 86(5):429-436. PubMed ID: 32684027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
    Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
    Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled study of the efficacy of preoperative somatostatin administration in the prevention of postoperative complications following pancreaticoduodenectomy.
    Wang W; Tian B; Babu SR; Zhang Y; Yang M
    Hepatogastroenterology; 2013 May; 60(123):400-5. PubMed ID: 23178468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative application of somatostatin analogs for pancreatic surgery-current status in Germany.
    Volk A; Nitschke P; Johnscher F; Rahbari N; Welsch T; Reißfelder C; Weitz J; Distler M; Mees ST
    Langenbecks Arch Surg; 2016 Nov; 401(7):1037-1044. PubMed ID: 27628685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duct-to-Mucosa vs Invagination for Pancreaticojejunostomy after Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial from a Single Surgeon.
    Bai X; Zhang Q; Gao S; Lou J; Li G; Zhang Y; Ma T; Zhang Y; Xu Y; Liang T
    J Am Coll Surg; 2016 Jan; 222(1):10-8. PubMed ID: 26577499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.